CAR-T therapies proliferate in the body and hunt down a wider range of pathological B-cells, in more tissues, than shorter-lived antibodies (Shutterstock)
Candid conversations with C-suite leaders.
Keep up with strategy, innovation and evolving trends across life science industries.
